<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02939313</url>
  </required_header>
  <id_info>
    <org_study_id>00030506</org_study_id>
    <secondary_id>P50AA010761</secondary_id>
    <nct_id>NCT02939313</nct_id>
  </id_info>
  <brief_title>Cortical rTMS as a Tool to Change Brain Reactivity to Alcohol Cues</brief_title>
  <acronym>ARC4</acronym>
  <official_title>Charleston ARC Clinical Project 4 Cortical rTMS as a Tool to Change Craving and Brain Reactivity to Alcohol Cues</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this investigation is to determine if, in heavy alcohol users, a single session
      of transcranial magnetic brain stimulation (TMS) over a brain region involved in craving
      (medial prefrontal cortex) and a brain region involved in cogntive control (dorsolateral
      prefrontal cortex) can lower an individual's craving and brain response to alcohol cues. This
      study involves a screening visit, followed by three visits which involve brain imaging (using
      functional MRI) and brain stimulation (using TMS). There is also an additional Magnetic
      resonance spectroscopy (MRS) exploratory Aim in which we will measure the concentration of
      glutamate in the prefrontal cortex before and after a session of TMS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Alcohol Use Disorders (AUDs) are prevalent, devastating, and difficult to treat. High relapse
      rates are likely due to factors that affect limbic and executive circuits in the brain,
      including vulnerability to salient cues and loss of cognitive control. Limbic drive and
      executive control are regulated by two cortical-subcortical neural circuits -the limbic loop
      that includes projections from the medial prefrontal cortex (mPFC) to the ventral striatum,
      and the executive control loop that includes projections from the dorsolateral prefrontal
      cortex (dlPFC) to the dorsal striatum. Optogenetic manipulation in animals has demonstrated a
      causal relationship between activity in these frontal-striatal circuits and drinking
      behavior. Consequently, an innovative and potentially fruitful new strategy in the treatment
      of AUDs in humans would be to selectively attenuate limbic circuitry (to reduce reward
      salience), and/or amplify executive circuitry, through targeted brain stimulation. Previous
      studies have demonstrated that a single session of 10 Hz transcranial magnetic stimulation
      (TMS) over the dlPFC can lead to a decrease in craving for alcohol, nicotine, and cocaine.
      Our laboratory has demonstrated that a single session of continuous theta burst (cTBS) TMS
      over the mPFC can also decrease craving, as well as the brain response to drug cues in
      cocaine users (Hanlon et al, in review) and alcohol users (see Significance). The overarching
      goal of this proposal is to determine which of these two TMS strategies - amplifying dlPFC
      activity or inhibiting mPFC activity - is more efficacious in decreasing alcohol craving and
      the brain response to cues. This will provide an evidence-based foundation for cortical
      target selection in future TMS clinical trials - an innovative treatment strategy for AUD
      patients.

      As a recent FDA-approved treatment for depression, there is a growing interest in
      investigating TMS as a treatment for drug and alcohol use disorders. By changing the
      frequency and pattern of stimulation, it is possible to induce a long-term potentiation (LTP)
      or long-term depression (LTD) of activity in the cortical area stimulated as well in its
      monosynaptic targets. To date, nearly all published reports of brain stimulation as a tool
      for decreasing craving have focused on applying LTP-like stimulation (typically 10 Hz) to the
      dlPFC, thereby strengthening executive control circuitry. An alternative approach is to apply
      LTD-like TMS (such as cTBS) to the mPFC, thereby weakening limbic drive circuitry (which is
      engaged during craving). A sham TMS-controlled crossover study of 12 heavy alcohol users in
      our lab indicated that a single dose of mPFC cTBS decreases self-reported craving and the
      BOLD response to alcohol cues in the mPFC and striatum (limbic regions involved in craving).
      Using MR spectroscopy, we further demonstrated that cTBS-reduced the glutamine concentration
      in the mPFC, which may be related to the decrease in BOLD signal and functional connectivity
      with this region. Before moving forward with large and expensive multisite clinical trials,
      it is important to determine which cortical target (mPFC vs dlPFC) is likely to have a
      greater effect on the brain response to alcohol cues (Aim 1), and which will have a greater
      effect on self-reported craving (Aim 2) -a major factor contributing to relapse and sustained
      heavy drinking among individuals with AUDs. In this three-visit crossover design, a cohort of
      non-treatment seeking AUD individuals will receive sham, mPFC, or dlPFC TMS at each visit
      followed by alcohol-cue induced BOLD imaging and MR Spectroscopy. We will determine whether
      LTD-like mPFC TMS is more effective than LTP-like dlPFC TMS in:

      Aim 1: Reducing alcohol cue-elicited brain activity in limbic circuitry. Participants will be
      exposed to our well-established fMRI alcohol cue paradigm. We will measure the percent BOLD
      signal change within a network of limbic regions typically activated by alcohol cues (e.g.
      mPFC, ACC, striatum) (Schacht et al., 2014), as well as functional connectivity between these
      regions (using psychophysiologic interactions). We will test the hypotheses that 1) both
      LTD-like stimulation to the mPFC (via cTBS) and LTP-like stimulation to the dlPFC (via 10Hz
      TMS) will significantly decrease alcohol cue-induced activation of limbic circuitry compared
      to sham stimulation and 2) this attenuating effect will be more robust when stimulation is
      targeted at the mPFC directly with cTBS stimulation (rather than indirectly via 10 Hz dlPFC
      stimulation).

      Aim 2: Reducing self-reported alcohol craving. Using intermittent self-reported assessments
      of the desire to drink alcohol throughout the experimental sessions (before, during, and at
      several time points after the TMS treatment), we will test the hypothesis that LTD-like
      stimulation to the mPFC (via cTBS) will decrease self-reported alcohol craving more than will
      LTP-like stimulation to the dlPFC (via 10Hz TMS).

      Finally, to develop a comprehensive and evidence-based foundation for future clinical trials,
      we will also explore the effects of these innovative brain stimulation treatment strategies
      on neurochemistry:

      Exploratory Aim 3: Regional neurochemistry. Through MR Spectroscopy, we will test the
      hypothesis that the effects of TMS on the outcomes of Aim 1 &amp; 2 are mediated by changes in
      mPFC excitatory/inhibitory neurochemical balance (i.e., changes in glutamate, glutamine, GABA
      concentrations).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent signal change in the MPFC</measure>
    <time_frame>immediately after the treatment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent signal change in the DLPFC</measure>
    <time_frame>immediately after the treatment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in craving score</measure>
    <time_frame>immediately after the treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in glutmate concentration</measure>
    <time_frame>immediately after the treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in GABA concentration</measure>
    <time_frame>immediately after the treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Alcohol Dependance</condition>
  <arm_group>
    <arm_group_label>medial prefrontal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individuals will receive medial prefrontal cortex stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dorsolateral prefrontal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individuals will receive dorsolateral prefrontal cortex stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Individuals will receive sham stimulation to the medial prefrontal and dorsolateral prefrontal cortex</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>medial prefrontal cortex</intervention_name>
    <description>a form of theta burst stimulation that noninvasively induces a depression in brain reactivity</description>
    <arm_group_label>medial prefrontal</arm_group_label>
    <other_name>medial prefrontal</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>dorsolateral prefrontal cortex</intervention_name>
    <description>a form of transcranial magnetic stimulation that noninvasively induces an increase in brain reactivity</description>
    <arm_group_label>dorsolateral prefrontal</arm_group_label>
    <other_name>dorsolateral prefrontal</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham</intervention_name>
    <description>sham stimulation</description>
    <arm_group_label>sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Age 21-40; Current alcohol use greater than 20 standard drinks per
        week; Current DSM-5 Alcohol Use Disorder diagnosis, including the loss of control item;
        Currently not engaged in, and do not want treatment for, alcohol related problems; Able to
        read and understand questionnaires and informed consent; Lives within 50 miles of the study
        site. Exclusion Criteria: [These are listed in greater detail in the CIA Core] Any current
        DSM-5 Axis I diagnosis except Alcohol or Nicotine Use Disorder; Current use of any
        psychoactive substance except nicotine and marijuana or medication as evidenced by
        self-report or urine drug screen; History of head trauma or epilepsy; Current suicidal or
        homicidal ideation; Presence of ferrous metal in the body, as evidenced by metal screening
        and self-report; Severe claustrophobia or extreme obesity that preclude placement in the
        MRI scanner. For female participants, pregnancy, as evidenced by a urine pregnancy test
        administered on the day of the scanning session.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Colleen A Hanlon, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James Prisciandaro, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Colleen A Hanlon, Ph.D.</last_name>
    <phone>(843) 792-5732</phone>
    <email>hanlon@musc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Millie H Griffin, B.A.</last_name>
    <phone>843 792 2335</phone>
    <email>grifm@musc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colleen A Hanlon, Ph.D.</last_name>
      <phone>843-792-5732</phone>
      <email>hanlon@musc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sinha R. New findings on biological factors predicting addiction relapse vulnerability. Curr Psychiatry Rep. 2011 Oct;13(5):398-405. doi: 10.1007/s11920-011-0224-0. Review.</citation>
    <PMID>21792580</PMID>
  </reference>
  <reference>
    <citation>Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005 Aug;162(8):1403-13. Review.</citation>
    <PMID>16055761</PMID>
  </reference>
  <reference>
    <citation>Sinha R, Catapano D, O'Malley S. Stress-induced craving and stress response in cocaine dependent individuals. Psychopharmacology (Berl). 1999 Mar;142(4):343-51.</citation>
    <PMID>10229058</PMID>
  </reference>
  <reference>
    <citation>Lee JL, Milton AL, Everitt BJ. Cue-induced cocaine seeking and relapse are reduced by disruption of drug memory reconsolidation. J Neurosci. 2006 May 31;26(22):5881-7.</citation>
    <PMID>16738229</PMID>
  </reference>
  <reference>
    <citation>Volkow ND, Wang GJ, Fowler JS, Tomasi D. Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol. 2012;52:321-36. doi: 10.1146/annurev-pharmtox-010611-134625. Epub 2011 Sep 27. Review.</citation>
    <PMID>21961707</PMID>
  </reference>
  <reference>
    <citation>Bolla K, Ernst M, Kiehl K, Mouratidis M, Eldreth D, Contoreggi C, Matochik J, Kurian V, Cadet J, Kimes A, Funderburk F, London E. Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci. 2004 Fall;16(4):456-64.</citation>
    <PMID>15616172</PMID>
  </reference>
  <reference>
    <citation>Bolla KI, Eldreth DA, London ED, Kiehl KA, Mouratidis M, Contoreggi C, Matochik JA, Kurian V, Cadet JL, Kimes AS, Funderburk FR, Ernst M. Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage. 2003 Jul;19(3):1085-94.</citation>
    <PMID>12880834</PMID>
  </reference>
  <reference>
    <citation>Hanlon CA, Wesley MJ, Stapleton JR, Laurienti PJ, Porrino LJ. The association between frontal-striatal connectivity and sensorimotor control in cocaine users. Drug Alcohol Depend. 2011 Jun 1;115(3):240-3. doi: 10.1016/j.drugalcdep.2010.11.008. Epub 2010 Dec 28.</citation>
    <PMID>21193273</PMID>
  </reference>
  <reference>
    <citation>Gu H, Salmeron BJ, Ross TJ, Geng X, Zhan W, Stein EA, Yang Y. Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity. Neuroimage. 2010 Nov 1;53(2):593-601. doi: 10.1016/j.neuroimage.2010.06.066. Epub 2010 Jul 11.</citation>
    <PMID>20603217</PMID>
  </reference>
  <reference>
    <citation>Bear MF, Malenka RC. Synaptic plasticity: LTP and LTD. Curr Opin Neurobiol. 1994 Jun;4(3):389-99. Review.</citation>
    <PMID>7919934</PMID>
  </reference>
  <reference>
    <citation>Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron. 2004 Sep 30;44(1):5-21. Review.</citation>
    <PMID>15450156</PMID>
  </reference>
  <reference>
    <citation>Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron. 2005 Jan 20;45(2):201-6.</citation>
    <PMID>15664172</PMID>
  </reference>
  <reference>
    <citation>Di Lazzaro V, Pilato F, Saturno E, Oliviero A, Dileone M, Mazzone P, Insola A, Tonali PA, Ranieri F, Huang YZ, Rothwell JC. Theta-burst repetitive transcranial magnetic stimulation suppresses specific excitatory circuits in the human motor cortex. J Physiol. 2005 Jun 15;565(Pt 3):945-50. Epub 2005 Apr 21.</citation>
    <PMID>15845575</PMID>
  </reference>
  <reference>
    <citation>Verbruggen F, Aron AR, Stevens MA, Chambers CD. Theta burst stimulation dissociates attention and action updating in human inferior frontal cortex. Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13966-71. doi: 10.1073/pnas.1001957107. Epub 2010 Jul 14.</citation>
    <PMID>20631303</PMID>
  </reference>
  <reference>
    <citation>Cho SS, Ko JH, Pellecchia G, Van Eimeren T, Cilia R, Strafella AP. Continuous theta burst stimulation of right dorsolateral prefrontal cortex induces changes in impulsivity level. Brain Stimul. 2010 Jul;3(3):170-6. doi: 10.1016/j.brs.2009.10.002. Epub 2009 Oct 31.</citation>
    <PMID>20633446</PMID>
  </reference>
  <reference>
    <citation>Jacobson L, Javitt DC, Lavidor M. Activation of inhibition: diminishing impulsive behavior by direct current stimulation over the inferior frontal gyrus. J Cogn Neurosci. 2011 Nov;23(11):3380-7. doi: 10.1162/jocn_a_00020. Epub 2011 Mar 31.</citation>
    <PMID>21452949</PMID>
  </reference>
  <reference>
    <citation>Camprodon JA, Mart√≠nez-Raga J, Alonso-Alonso M, Shih MC, Pascual-Leone A. One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving. Drug Alcohol Depend. 2007 Jan 5;86(1):91-4. Epub 2006 Sep 12.</citation>
    <PMID>16971058</PMID>
  </reference>
  <reference>
    <citation>Politi E, Fauci E, Santoro A, Smeraldi E. Daily sessions of transcranial magnetic stimulation to the left prefrontal cortex gradually reduce cocaine craving. Am J Addict. 2008 Jul-Aug;17(4):345-6. doi: 10.1080/10550490802139283.</citation>
    <PMID>18612892</PMID>
  </reference>
  <reference>
    <citation>Barr MS, Fitzgerald PB, Farzan F, George TP, Daskalakis ZJ. Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders. Curr Drug Abuse Rev. 2008 Nov;1(3):328-39. Review.</citation>
    <PMID>19630729</PMID>
  </reference>
  <reference>
    <citation>Wing VC, Barr MS, Wass CE, Lipsman N, Lozano AM, Daskalakis ZJ, George TP. Brain stimulation methods to treat tobacco addiction. Brain Stimul. 2013 May;6(3):221-30. doi: 10.1016/j.brs.2012.06.008. Epub 2012 Jul 9. Review.</citation>
    <PMID>22809824</PMID>
  </reference>
  <reference>
    <citation>Hanlon CA, Canterberry M, Taylor JJ, DeVries W, Li X, Brown TR, George MS. Probing the frontostriatal loops involved in executive and limbic processing via interleaved TMS and functional MRI at two prefrontal locations: a pilot study. PLoS One. 2013 Jul 9;8(7):e67917. doi: 10.1371/journal.pone.0067917. Print 2013.</citation>
    <PMID>23874466</PMID>
  </reference>
  <reference>
    <citation>Bestmann S, Baudewig J, Siebner HR, Rothwell JC, Frahm J. Functional MRI of the immediate impact of transcranial magnetic stimulation on cortical and subcortical motor circuits. Eur J Neurosci. 2004 Apr;19(7):1950-62.</citation>
    <PMID>15078569</PMID>
  </reference>
  <reference>
    <citation>Bohning DE, Shastri A, Lomarev MP, Lorberbaum JP, Nahas Z, George MS. BOLD-fMRI response vs. transcranial magnetic stimulation (TMS) pulse-train length: testing for linearity. J Magn Reson Imaging. 2003 Mar;17(3):279-90.</citation>
    <PMID>12594717</PMID>
  </reference>
  <reference>
    <citation>Fox MD, Buckner RL, White MP, Greicius MD, Pascual-Leone A. Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate. Biol Psychiatry. 2012 Oct 1;72(7):595-603. doi: 10.1016/j.biopsych.2012.04.028. Epub 2012 Jun 1.</citation>
    <PMID>22658708</PMID>
  </reference>
  <reference>
    <citation>Vernet M, Bashir S, Yoo WK, Oberman L, Mizrahi I, Ifert-Miller F, Beck CJ, Pascual-Leone A. Reproducibility of the effects of theta burst stimulation on motor cortical plasticity in healthy participants. Clin Neurophysiol. 2014 Feb;125(2):320-6. doi: 10.1016/j.clinph.2013.07.004. Epub 2013 Aug 7.</citation>
    <PMID>23932365</PMID>
  </reference>
  <reference>
    <citation>Wilcox CE, Teshiba TM, Merideth F, Ling J, Mayer AR. Enhanced cue reactivity and fronto-striatal functional connectivity in cocaine use disorders. Drug Alcohol Depend. 2011 May 1;115(1-2):137-44. doi: 10.1016/j.drugalcdep.2011.01.009. Epub 2011 Apr 3.</citation>
    <PMID>21466926</PMID>
  </reference>
  <reference>
    <citation>Prisciandaro JJ, McRae-Clark AL, Myrick H, Henderson S, Brady KT. Brain activation to cocaine cues and motivation/treatment status. Addict Biol. 2014 Mar;19(2):240-9. doi: 10.1111/j.1369-1600.2012.00446.x. Epub 2012 Mar 28.</citation>
    <PMID>22458561</PMID>
  </reference>
  <reference>
    <citation>Borckardt JJ, Nahas Z, Koola J, George MS. Estimating resting motor thresholds in transcranial magnetic stimulation research and practice: a computer simulation evaluation of best methods. J ECT. 2006 Sep;22(3):169-75.</citation>
    <PMID>16957531</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 1, 2016</study_first_submitted>
  <study_first_submitted_qc>October 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2016</study_first_posted>
  <last_update_submitted>October 26, 2016</last_update_submitted>
  <last_update_submitted_qc>October 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Colleen Hanlon</investigator_full_name>
    <investigator_title>Colleen A. Hanlon, Ph.D.</investigator_title>
  </responsible_party>
  <keyword>alcohol</keyword>
  <keyword>addiction</keyword>
  <keyword>cTBS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be shared with the National Institute of Health Neuroimaging Biorepository at the completion of the study</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

